In addition, the activation of BMP signaling has been shown to cause myopathy with reduced muscle mass, central nuclei in several muscle fibers and increased fat deposition in Fbn2 null mice during early postnatal muscle development, suggesting that the BMP signaling pathway may have different effects depending on microenvironment [41]. Here, FBN2 is linked to myopathy.